Pharmaceuticals & Biotech Healthcare Sector

Xencor

Market Cap: US$547.3m

A clinical-stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibodies for the treatment of asthma and allergic diseases, autoimmune diseases, and cancer.

Elite Pharmaceuticals

Market Cap: US$546.6m

A specialty pharmaceutical company, engages in the development, manufacture, and sale of oral, controlled-release products, and generic pharmaceuticals.

Eton Pharmaceuticals

Market Cap: US$543.1m

A pharmaceutical company, focuses on developing and commercializing treatments for rare diseases.

InnovAge Holding

Market Cap: US$543.0m

Manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in its homes and communities.

Kura Oncology

Market Cap: US$540.2m

A clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer.

Mind Medicine (MindMed)

Market Cap: US$534.2m

A clinical stage biopharmaceutical company, develops novel products to treat brain health disorders.

Butterfly Network

Market Cap: US$529.2m

Develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally.

Owens & Minor

Market Cap: US$527.1m

Operates as a healthcare solutions company worldwide.

OrthoPediatrics

Market Cap: US$523.9m

A medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally.

LifeMD

Market Cap: US$522.6m

Operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States.

Enhabit

Market Cap: US$519.5m

Provides home health and hospice services in the United States.

Stoke Therapeutics

Market Cap: US$518.7m

An early-stage biopharmaceutical company, engages in the development of treatments for severe genetic diseases by upregulating protein expression.

Tyra Biosciences

Market Cap: US$510.0m

A clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology in the United States.

Auna

Market Cap: US$504.5m

A healthcare service provider, operates hospitals and clinics in Mexico, Peru, and Colombia.

Semler Scientific

Market Cap: US$501.0m

Provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States.

Upstream Bio

Market Cap: US$500.8m

A clinical-stage biotechnology company, develops treatments for inflammatory diseases focusing on severe respiratory disorders.

Axogen

Market Cap: US$498.3m

Develops and commercializes technologies for peripheral nerve regeneration and repair worldwide.

Community Health Systems

Market Cap: US$497.5m

Owns, leases, and operates general acute care hospitals in the United States.

Capricor Therapeutics

Market Cap: US$496.4m

A clinical-stage biotechnology company, engages in the development of transformative cell and exosome-based therapeutics for treating duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs in the United States.

REGENXBIO

Market Cap: US$494.6m

A clinical-stage biotechnology company, provides gene therapies that deliver functional genes to cells with genetic defects in the United States.

Relay Therapeutics

Market Cap: US$487.8m

Operates as a clinical-stage precision medicines company.

Virtus Health

Market Cap: AU$705.2m

Virtus Health Limited provides various healthcare services in Australia, Denmark, the United Kingdom, Ireland, and Singapore.

Allergy Therapeutics

Market Cap: UK£357.5m

A commercial biotechnology company, focuses on the diagnosis and treatment of allergic disorders.

Opthea

Market Cap: AU$738.8m

A clinical-stage biopharmaceutical company, develops and commercializes drugs for eye diseases in Australia and the United States.

Claritev

Market Cap: US$479.1m

Provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States.

Zenas BioPharma

Market Cap: US$479.0m

A clinical-stage biopharmaceutical company, engages in the development and commercialization of transformative immunology-based therapies.

Amylyx Pharmaceuticals

Market Cap: US$477.8m

A clinical-stage pharmaceutical company, engages in the discovery and development of treatment options for neurodegenerative diseases and endocrine conditions in the United States.

Arvinas

Market Cap: US$472.3m

A clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins.

Zevra Therapeutics

Market Cap: US$468.6m

A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.

Altimmune

Market Cap: US$468.0m

A clinical stage biopharmaceutical company, focuses on developing treatments for obesity, metabolic, and liver diseases.

Cullinan Therapeutics

Market Cap: US$465.6m

A clinical-stage biopharmaceutical company, develops therapies for autoimmune diseases and cancer in the United States.

Theravance Biopharma

Market Cap: US$465.0m

A biopharmaceutical company, develops and commercializes of medicines in the United States.

Talkspace

Market Cap: US$461.8m

Operates as a virtual behavioral healthcare company that connects patients with licensed mental health providers in the United States.

Healius

Market Cap: AU$708.0m

Provides specialty diagnostic services to consumer and practitioners in Australia.

Clarity Pharmaceuticals

Market Cap: AU$707.0m

A clinical stage radiopharmaceutical company, engages in research and development and clinical stage radiopharmaceuticals products in Australia and the United States.

Oxford Biomedica

Market Cap: UK£339.2m

A contract development and manufacturing organization, focuses on delivering therapies to patients worldwide.